Results 111 to 120 of about 4,280 (166)

HLA-E[pHLA-G] complex-specific monoclonal antibody enhancing NK activity in multiple myeloma. [PDF]

Blood Adv
Ahmad MA, Radinsky O, Kaufman B, Waidha K, Gharra E, Dim S, Manikandan DB, Ofir N, Jäger D, Meyer M, Elkabets M, Campbell KS, Zektser M, Gazit R, Rouvio O, Momburg F, Porgador A.   +16 more
europepmc   +1 more source

Natural Killer Cell Dysfunction Causes Eosinophil Accumulation in Chronic Rhinosinusitis With Nasal Polyps. [PDF]

Clin Transl Allergy
Sato Y, Nakashima D, Inoue N, Osada E, Hirota T, Tsunemi Y, Otori N, Yoshikawa M, Tamari M, Nakayama T.   +9 more
europepmc   +1 more source

Targeting MHC-E as a new strategy for vaccines and immunotherapeutics. [PDF]

Nat Rev Immunol
Früh K, Borrow P, Gillespie GM, McMichael AJ, Picker LJ.   +4 more
europepmc   +1 more source

Phenotypic and epigenetic profiles of circulating NK cells in spontaneous HIV-1 controllers. [PDF]

EBioMedicine
Huber A, Groenendijk AL, Navas A, Vadaq N, Ruijten SDE, Matzaraki V, Fok ET, Gurbanova A, Vos WAJW, Blaauw MJT, van Eekeren LE, Jacobs-Cleophas MCP, Stalenhoef J, Berrevoets M, van der Molen R, van der Meer A, de Jonge MI, Martens JHA, Rokx C, Verbon A, van Lunzen J, Koenen HJPM, Netea MG, van der Ven AJAM, Joosten LAB, Dos Santos JC.   +25 more
europepmc   +1 more source

The Expanding Role of HLA-E in Host Defense: A Target for Broadly Applicable Vaccines and Immunotherapies. [PDF]

Cells
Rafieiyan M, La Manna MP, Dieli F, Caccamo N, Badami GD.   +4 more
europepmc   +1 more source

Cancer viroimmunotherapy platforms based on varicella-zoster virus and cytomegalovirus. [PDF]

Mol Ther
Jiang H, Peng KW, Russell SJ.
europepmc   +1 more source

Epstein-Barr virus associated diseases: Immune alterations and targeted approaches. [PDF]

Front Immunol
Cao S, Xiong J, Zhao J, Zhao WL.
europepmc   +1 more source

Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia. [PDF]

J Transl Med
Ferron E, Jullien M, Gagne K, Retière C.   +3 more
europepmc   +1 more source

Hantaan virus-derived peptides that stabilize HLA-E could abrogate inhibition of CD56dimNKG2A+ NK cells. [PDF]

PLoS Pathog
Xue M, Tang K, Zhang Y, Xu X, Zhang C, Zuo J, Wang F, Zhang X, Zheng X, Zhuang R, Zhang Y, Jin B, Ma Y.   +12 more
europepmc   +1 more source

Adaptive NKG2C⁺ NK cells in cytomegalovirus seropositive individuals predominantly lack NKR-P1A receptor expression. [PDF]

Eur J Immunol
Alkassab MB, Shaikh FA, Hamm C, Rahim MMA.   +3 more
europepmc   +1 more source